FDA Office Of Nonprescription Drugs To Assume Switch Management Duties
This article was originally published in The Tan Sheet
Executive Summary
FDA's recently-christened Office of Nonprescription Drugs will take over project management responsibilities for Rx-to-OTC switches from the primary review division within the Center for Drug Evaluation & Research, according to the agency
You may also be interested in...
FDA Clearance May Thwart Monograph Goal; Ganley Talks Turkey About ONP
The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA improves its document clearance process, according to ONP head Charles Ganley, MD
FDA Clearance May Thwart Monograph Goal; Ganley Talks Turkey About ONP
The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA improves its document clearance process, according to ONP head Charles Ganley, MD
FDA Clearance May Thwart Monograph Goal; Ganley Talks Turkey About ONP
The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA improves its document clearance process, according to ONP head Charles Ganley, MD